Treace Medical Concepts Inc reports results for the quarter ended in September - Earnings Summary

Treace Medical Concepts

08/11/2022 22:53

* Treace Medical Concepts Inc  TMCI.OQ  reported a quarterly
adjusted loss of 22 cents​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of 29 cents per share.
    * Revenue rose 52.9% to $33.06 million from a year ago;
analysts
expected $30.07 million. 
    * Treace Medical Concepts Inc's reported EPS for the quarter
was a
loss of 22 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Treace Medical Concepts Inc shares had fallen by 4.5% this
quarter and gained 13.1% so far this year.
    * The company reported a quarterly loss of $12.13 million.
    * Wall Street's median 12-month price target for Treace
Medical
Concepts Inc is $28.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 10:52 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.29          -0.22          Beat
 Jun. 30 2022      -0.20          -0.31          Missed
 Mar. 31 2022      -0.20          -0.16          Beat
 Dec. 31 2021      0.00           -0.12          Missed